These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6531397)
41. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems. Onyeji CO; Omoruyi SI; Oladimeji FA Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103 [TBL] [Abstract][Full Text] [Related]
42. Properties of cyclodextrin polymer as a tabletting aid. Fenyvesi E; Shirakura O; Szejtli J; Nagai T Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):665-9. PubMed ID: 6733812 [No Abstract] [Full Text] [Related]
43. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam. Cadel S; Bongrani S Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898 [No Abstract] [Full Text] [Related]
44. Effect of cyclodextrin complexation on aqueous solubility and photostability of phenothiazine. Lutka A Pharmazie; 2000 Feb; 55(2):120-3. PubMed ID: 10723770 [TBL] [Abstract][Full Text] [Related]
45. A comparative study of modified starches in direct compression of a poorly water soluble drug (hydrochlorothiazide). Okafor IS; Ofoefule SI; Udeala OK Boll Chim Farm; 2001; 140(1):36-9. PubMed ID: 11338775 [TBL] [Abstract][Full Text] [Related]
46. Beta-cyclodextrin as a direct compression excipient compared to conventional ones. Saleh SI J Pharm Belg; 1993; 48(5):371-7. PubMed ID: 8120790 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of cyclodextrin polymer as an additive for furosemide tablet. Fenyvesi E; Takayama K; Szejtli J; Nagai T Chem Pharm Bull (Tokyo); 1984 Feb; 32(2):670-7. PubMed ID: 6733813 [No Abstract] [Full Text] [Related]
49. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics. Nakai Y; Yamamoto K; Terada K; Kajiyama A Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437 [No Abstract] [Full Text] [Related]
50. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound. Frank SG; Kavaliunas DR J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576 [TBL] [Abstract][Full Text] [Related]
51. Inclusion compounds of lankacidin-group antibiotics with cyclodextrins. Harada S; Okada J; Takeda M; Yamazaki T J Antibiot (Tokyo); 1985 Jul; 38(7):877-85. PubMed ID: 4030501 [TBL] [Abstract][Full Text] [Related]
52. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method. Fathy M; Sheha M Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779 [TBL] [Abstract][Full Text] [Related]
53. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets. Fridriksdóttir H; Loftsson T; Gudmundsson JA; Bjarnason GJ; Kjeld M; Thorsteinsson T Pharmazie; 1996 Jan; 51(1):39-42. PubMed ID: 8999433 [TBL] [Abstract][Full Text] [Related]
54. [Possible utility of beta-cyclodextrin complexation in the preparation of biphenyl acetic acid suppositories]. Uekama K; Maeda T; Arima H; Irie T; Hirayama F Yakugaku Zasshi; 1986 Dec; 106(12):1126-30. PubMed ID: 3559906 [No Abstract] [Full Text] [Related]
56. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin. Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071 [TBL] [Abstract][Full Text] [Related]
57. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin. Chowdary KP; Kamalakara RG Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284 [TBL] [Abstract][Full Text] [Related]
58. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes. Vincieri FF; Mazzi G; Papini P; Gelsomini N Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770 [No Abstract] [Full Text] [Related]